Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: Reconstitution of phenotype and HLA-restricted T-cell responses

Tissue Antigens

Volumn 68, Issue 3, 2006, Pages 210-219

  Chen, Z ^a   De Kauwe, A L ^a   Keech, C ^a   Wijburg, O ^a   Simpfendorfer, K ^a   Alexander, W S ^b   McCluskey, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

HLA haplotype; MHC class II; T cell repertoire; Transgenic; Yeast artificial chromosome

Indexed keywords

CD4 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQ3 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DRB4 ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL CHROMOSOME; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HAPLOTYPE; HLA SYSTEM; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA ARIZONAE; SALMONELLOSIS; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHROMOSOMES, ARTIFICIAL, YEAST; DISEASE MODELS, ANIMAL; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHENOTYPE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TRANSFECTION;

ANIMALIA; MURINAE; MUS MUSCULUS; SALMONELLA ENTERICA;

EID: 33748439524     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00656.x     Document Type: Article

References (51)

1. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991: 9: 493-525.
2. McDevitt HO. The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr Opin Immunol 1998: 10: 677-81.
3. Lechler R, Warrens A. HLA in Health and Disease, 2nd edn. London: Academic Press, 2000.
4. Dawkins RL, Christiansen FT, Kay PH et al. Disease associations with complotypes, supratypes and haplotypes. Immunol Rev 1983: 70: 1-22.
5. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes 2000: 49: 548-54.
6. Das P, Drescher KM, Geluk A, Bradley DS, Rodriguez M, David CS. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum Immunol 2000: 61: 279-89.
7. Thorsby E. HLA associated disease susceptibility: which genes are primarily responsible? The Immunologist 1995: 3: 51.
8. Sonderstrup G, Cope AP, Patel S et al. HLA class II transgenic mice: models of the human CD4+ T-cell immune response. Immunol Rev 1999: 172: 335-43.
9. Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases. Rev Immunogenet 2000: 2: 105-14.
10. Acha-Orbea H, McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci U S A 1987: 84: 2435-9.
11. Acha-Orbea H, Scarpellino L. Nonobese diabetic and nonobese nondiabetic mice have unique MHC class II haplotypes. Immunogenetics 1991: 34: 57-9.
12. Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 1996: 47: 37-48.
13. Taneja V, Griffiths MM, Luthra H, David CS. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol 1998: 10: 1449-57.
14. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999: 167: 257-74.
15. Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001: 107: 871-80.
16. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995: 13: 179-200.
17. Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A 1994: 91: 6151-5.
18. Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci U S A 1996: 93: 1814-9.
19. Woods A, Chen HY, Trumbauer ME, Sirotina A, Cummings R, Zaller DM. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med 1994: 180: 173-81.
20. Pan S, Taneja V, Griffiths MM, Luthra H, David CS. Complementation between HLA-DR4 (DRB1&z.ast;0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. Hum Immunol 1999: 60: 816-25.
21. Cheng S, Baisch J, Krco C et al. Expression and function of HLA-DQ8 (DQA1&z.ast;0301/DQB1&z.ast;0302) genes in transgenic mice. Eur J Immunogenet 1996: 23: 15-20.
22. Chen Z, Dudek N, Wijburg O et al. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. J Immunol 2002: 168: 3050-6.
23. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978: 298: 869-71.
24. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989: 86: 10049-53.
25. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-13.
26. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996: 85: 311-8.
27. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990: 322: 1836-41.
28. Lernmark A. Molecular biology of IDDM. Diabetologia 1994: 37 (Suppl 2): S73-81.
29. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
30. Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong YM. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum Immunol 2002: 63: 301-10.
31. Abderrahim H, Sambucy JL, Iris F et al. Cloning the human major histocompatibility complex in YACs. Genomics 1994: 23: 520-7.
32. Markie D. Markers, selection, and media in YAC cloning. Methods Mol Biol 1996: 54: 359-71.
33. Silverman GA. Purification of YAC-containing total yeast DNA. Methods Mol Biol 1996: 54: 65-8.
34. Ragoussis J. Restriction analysis of YACs. Methods Mol Biol 1996: 54: 69-74.
35. Ogilvie DJ, James LA. End rescue from YACs using the vectorette. Methods Mol Biol 1996: 54: 131-8.
36. Pavan WJ, Hieter P, Reeves RH. Generation of deletion derivatives by targeted transformation of human-derived yeast artificial chromosomes. Proc Natl Acad Sci U S A 1990: 87: 1300-4.
37. Davies NP, Huxley C. YAC transfer into mammalian cells by cell fusion. Methods Mol Biol 1996: 54: 281-92.
38. Lee JT, Jaenisch R. A method for high efficiency YAC lipofection into murine embryonic stem cells. Nucleic Acids Res 1996: 24: 5054-5.
39. Madsen L, Labrecque N, Engberg J et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A 1999: 96: 10338-43.
40. Killeen N, Sawada S, Littman DR. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. Embo J 1993: 12: 1547-53.
41. Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol 1980: 125: 293-9.
42. Spits H, Ijssel H, Thompson A, de Vries JE. Human T4+ and T8+ cytotoxic T lymphocyte clones directed at products of different class II major histocompatibility complex loci. J Immunol 1983: 131: 678-83.
43. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 1990: 343: 71-4.
44. Russ GR, Pascoe V, d'Apice AJ, Seymour AE. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes. Transplant Proc 1986: 18: 293-7.
45. Wijburg OL, Simmons CP, van Rooijen N, Strugnell RA. Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections. Eur J Immunol 2000: 30: 944-53.
46. Jakobovits A, Lamb BT, Peterson KR. Production of transgenic mice with yeast artificial chromosomes. Methods Mol Biol 2000: 136: 435-53.
47. Ito K, Bian HJ, Molina M et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 1996: 183: 2635-44.
48. Coligan JE, Kruisbeek AM, Margulies DH, Sjevacj EM, Strober W. Current Protocols in Immunology. New York: John Wiley & Sons Inc., 1992.
49. Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 1991: 147: 1292-8.
50. Hess J, Ladel C, Miko D, Kaufmann SH. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996: 156: 3321-6.
51. Tabata H, Kanai T, Yoshizumi H et al. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus. Hum Immunol 1998: 59: 549-60.